Pharmacare with no new medicines

Meeting with pricing officials shows that government’s true goal is to slash prices so low that no new medicines will come to Canada

OTTAWA, ON – December 10, 2019 – The changes to how the Patented Medicines Prices Review Board (PMPRB) calculates maximum prices allowed for new treatments in Canada, approved in the last days of the previous majority Liberal government, are “even worse than feared,” stated patient representatives after a four-hour meeting with PMPRB officials in Ottawa on December 10.

“We can only conclude that this strategy is tied to the publicly funded pharmacare proposals, also supported by the previous government,” said Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders. “It will be a drug plan that includes no new drugs and perhaps eliminates some existing ones.”

To see the full CORD press release, click here or visit https://www.newswire.ca/news-releases/pharmacare-with-no-new-medicines-803868005.html